Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks

Pheochromocytoma and paraganglioma are neuroendocrine neoplasms, originating in the adrenal medulla and in parasympathetic and sympathetic autonomic nervous system ganglia, respectively. They usually present as localized tumours curable with surgery. However, these tumours may exhibit heterogeneous...

Full description

Bibliographic Details
Main Authors: Giuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, Tullio Florio, Tiziana Feola, Manila Rubino, Federica de Cicco, Annamaria Colao, Antongiulio Faggiano, NIKE Group
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
pheochromocytoma
paraganglioma
immune checkpoint inhibitors
avelumab
atezolizumab
ipilimumab
Online Access:https://www.mdpi.com/2077-0383/10/1/88

Internet

https://www.mdpi.com/2077-0383/10/1/88

Similar Items